Use of serum drug concentrations in surgical patients

https://doi.org/10.1016/S0002-9610(88)80176-4Get rights and content

Surgical patients frequently require drug treatments that can be assessed with serum drug concentrations. Of the agents for which serum drug concentrations are routinely available, the aminoglycosides theophylline, vancomycin, digoxin, and phenytoin are used most frequently in surgical patients. When using serum drug concentrations, the clinician should have an understanding of the relationships (or lack of) between drug concentrations and therapeutic or toxic effects. When blood is collected for serum concentration determinations, the exact timing of the sample in relation to the dose must be considered. For some drugs, (such as the aminoglycosides, it is necessary to determine peak and trough concentrations, whereas for other agents, like theophylline, the average or mid-dose level may be more important to consider. There are many factors that affect serum drug concentrations. Among these are various disease states, obesity, fluid imbalances, the drug dosage form used, and concurrent drug use. Not all patients require serum drug concentration monitoring; however, with each drug there are high-risk patients who may benefit. When used properly, serum drug concentrations may be helpful in maximizing therapeutic benefits, minimizing or diagnosing drug toxicity, and assessing patient compliance with drug regimens.

References (53)

  • MawerGE et al.

    Prescribing aids for gentamicin

    Br J Clin Pharmacol

    (1974)
  • ZaskeDE

    Aminoglycosides

  • BowlesSK et al.

    Aminoglycoside commentary

  • LauermannMW et al.

    Assays of aminoglycoside antibiotics: purposes, procedures, and pitfalls

  • LoiratP et al.

    Increased glomerular filtration rate in patients with major burns and its effect on the pharmacokinetics of tobramycin

    N Engl J Med

    (1978)
  • ZaskeDE et al.

    Increased dosage requirements of gentamicin in burn patients

    J Trauma

    (1976)
  • BauerLA et al.

    Amikacin pharmacokinetics in morbidly obese patients

    Am J Hosp Pharm

    (1980)
  • LietmanPS et al.

    Aminoglycoside nephrotoxicity in humans

    Rev Infect Dis

    (1983)
  • RybakMJ et al.

    Monitoring vancomycin therapy

    Drug Intell Clin Pharm

    (1986)
  • MellorJA et al.

    Vancomycin ototoxicity in patients with normal renal function

    Br J Audiol

    (1984)
  • TraberPG et al.

    Vancomycin ototoxicity in a patient with normal renal function

    Ann Intern Med

    (1981)
  • FarberBF et al.

    Retrospective study of the toxicity of preparations of vancomycin from 1974 to 1981

    Antimicrob Agents Chemother

    (1983)
  • MoelleringRC

    Pharmacokinetics of vancomycin

    J Antimicrob Chemother

    (1984)
  • RotschaferJC et al.

    Pharmacokinetics of vancomycin: observations in 28 patients and dosage recommendations

    Antimicrob Agents Chemother

    (1982)
  • KrogstadDJ et al.

    Single-dose kinetics of intravenous vancomycin

    J Clin Pharmacol

    (1980)
  • SchaadUB et al.

    Clinical pharmacology and efficacy of vancomycin in pediatric patients

    J Pediatr

    (1980)
  • 1

    From the University of Georgia College of Pharmacy, Athens, Georgia and the Department of Surgery, Medical College of Georgia, Augusta, Georgia.

    View full text